Innovotech
Innovotech is a publicly traded Canadian contract research laboratory providing GMP- and ISO-accredited antimicrobial and biofilm testing services, plus proprietary MBEC Assay® kits and InnovoSIL™ Silver, to pharmaceutical, medical device, biotech, compounding pharmacy, and nutraceutical clients.
- Company typePublic
- Founded2001
- HeadquartersEdmonton, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Innovotech does
Innovotech Inc. is a publicly traded Canadian contract research organization (CRO) headquartered in Edmonton, Alberta, listed on the TSX Venture Exchange (IOT.V) and OTCQB (IOTCF). The company operates through its wholly-owned subsidiary Innovotech Labs Corporation, a GMP- and ISO/IEC 17025-accredited laboratory specializing in antimicrobial and biofilm testing services. Its core proprietary technology is the MBEC Assay® — a high-throughput 96-well biofilm inoculator (corresponding to ASTM E2799) available in multiple configurations and with substrate coatings (silicone, cellulose, hydroxyapatite, titanium dioxide) — together with the proprietary BEST Assay™ and BESTplus Assay® methods for customized biofilm eradication and surface testing. The laboratory also holds a Drug Establishment License and operates a Containment Level 2 facility with a library of approximately 3,000 microbial strains, and recently added MALDI-TOF MS capability for rapid organism identification.
The company generates revenue through two primary streams: fee-for-service contract research and testing (compendial microbiology, antimicrobial susceptibility testing per CLSI methods, GMP analytical chemistry using HPLC, GC, GC/MSD, FTIR, UV-Vis, and TOC instrumentation, medical device antimicrobial testing, stability and method development) sold directly to enterprise customers; and product sales of MBEC Assay® kits and InnovoSIL™ Silver antimicrobial silver through its e-commerce storefront, with kit pricing ranging from approximately USD $305 to USD $3,678 per unit depending on configuration. Customer segments are diversified across pharmaceutical, biotechnology, medical device, compounding pharmacy, and nutraceutical industries, with pharmaceutical and medical device manufacturers identified as primary verticals. End customers include companies requiring 510K and other regulatory submission support, USP and Ph.Eur compendial compliance, and high-throughput biofilm testing under physiologically relevant conditions.
Innovotech has been operating for 25+ years and maintains a small employee base of 11-50 staff concentrated at its Edmonton facilities (a head office at Suite C203, 2011-94 Street and a GMP lab at 9407 20 Ave NW). The company supplements operational funding with periodic non-dilutive Canadian government grants, most recently a CAD $234,000 NRC IRAP award in May 2026 to develop new medical device antimicrobial testing methods aligned with international regulatory changes. The company is led by CEO Craig Milne and presents regularly at retail-investor forums; its TSX-Venture-listed stock trades at CAD $0.10, consistent with a small-cap specialized CRO rather than a scaled testing platform.
Innovotech firmographics
Firmographics- Name
- Innovotech
- Legal name
- Innovotech Inc.
- Website
- https://innovotech.ca
- Company type
- Public
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Innovotech is a publicly traded Canadian contract research laboratory providing GMP- and ISO-accredited antimicrobial and biofilm testing services, plus proprietary MBEC Assay® kits and InnovoSIL™ Silver, to pharmaceutical, medical device, biotech, compounding pharmacy, and nutraceutical clients.
- Ownership category
- akta.pro rank
Innovotech industry classification
Industry- Product category
- Contract Research & Antimicrobial Testing Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)
Keywords
Where Innovotech is headquartered
LocationHeadquarters
- HQ city
- Edmonton
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Innovotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Contract Research Services: Fee-for-service antimicrobial, biofilm, microbiology, and analytical chemistry contract research and testing services for pharmaceutical, biotechnology, medical device, compounding pharmacy, and nutraceutical clients. Services include compendial testing, method development and validation, stability testing, and GMP analytics.
- MBEC Assay® Product Sales: Sale of proprietary MBEC Assay® biofilm inoculator kits in multiple formats (96-well base, trough base) with various coatings (uncoated, silicone, cellulose, hydroxyapatite, titanium dioxide). Sold directly via e-commerce storefront.
- InnovoSIL™ Silver Product Sales: Sale of InnovoSIL™ Silver antimicrobial silver-based product.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | MBEC Assay 96 Well Base (Uncoated): USD $305.00 – $2,342.50 |
| Unit Pricing | Pay-as-you-go | MBEC Assay Coated variants (Silicone, Cellulose, Hydroxyapatite, Titanium Dioxide): USD $482.50 – $3,677.50 |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Innovotech product offering
Product offeringCore offering
Innovotech is a GMP- and ISO/IEC 17025-accredited contract research laboratory that provides antimicrobial and biofilm testing services to pharmaceutical, biotechnology, medical device, compounding pharmacy, and nutraceutical clients. The company also manufactures and sells its proprietary MBEC Assay® biofilm inoculator kits and InnovoSIL™ Silver antimicrobial product directly through its e-commerce storefront.
Product overview
Innovotech provides a portfolio of laboratory testing services and proprietary testing products for antimicrobial and biofilm research. The core product line includes the MBEC Assay® system ( biofilm inoculator kits with 96-well and trough base formats) available with various surface coatings (silicone, cellulose, hydroxyapatite, titanium dioxide) for testing on different substrate materials. Supporting the assay products, Innovotech offers comprehensive contract research services including microbiology testing, antimicrobial susceptibility testing (MIC/MBC/MFC), medical device testing, and GMP analytical chemistry services. The company also markets InnovoSIL™ Silver as an antimicrobial agent product. Together, these products and services enable clients in pharmaceutical, biotechnology, medical device, and nutraceutical industries to evaluate antimicrobial efficacy, achieve regulatory compliance, and bring products to market.
Differentiator
Problem solved
Functional benefit
Brands
- MBEC Assay®: High-throughput biofilm inoculator assay used to determine the efficacy of antimicrobials against biofilms. Available in various configurations including 96 well base and trough base, with optional coatings such as silicone, titanium dioxide, hydroxyapatite, and cellulose.
- BEST Assay™
- InnovoSIL™ Silver
Products and services
- MBEC Assay® Biofilm Inoculator with 96 Well Base
- MBEC Assay® Biofilm Inoculator with Trough Base
- MBEC Assay® Coated Peg Variants
- InnovoSIL™ Silver
- Microbiology Testing Services
- MIC, MBC, MFC, and Toxicology Testing Services
- Medical Device Testing Services
- GMP Analytical Chemistry Testing Services
- BEST Assay™ Method Testing Service
Quantifiable outcome
- Assisted clients in achieving 510K regulatory approvals and other product regulatory submissions
- +1 more outcomes
Companies that use Innovotech
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
Innovotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Innovotech partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Innovotech competitors and assessment
Company assessmentDirect peers
- Nelson Laboratories: Specialized medical device testing laboratory offering antimicrobial, biocompatibility, and sterilization testing. Directly comparable to Innovotech's medical device antimicrobial testing services for FDA 510(k) submissions.
- bioMérieux: Specialist in in vitro diagnostics and industrial microbiology, including antimicrobial susceptibility testing and microbial identification (e.g., VITEK, MALDI-TOF BioTyper). Most directly comparable peer to Innovotech's antimicrobial testing and recent MALDI-TOF capability.
- Microbiologics: Producer of microbial reference strains and quality control organisms used by labs performing antimicrobial and diagnostic testing. Comparable to Innovotech's ~3,000-strain microbial collection and CL2 laboratory capabilities.
- ATCC (American Type Culture Collection): Global biological resource center providing authenticated microbial strains and reference materials to researchers and industry. Comparable to Innovotech's microbial strain collection and the strain-based testing services built around it.
Broad incumbents
- SGS: Global testing, inspection, and certification company with a life sciences microbiology and analytical chemistry practice serving pharma and medical device clients. Overlaps with Innovotech's GMP analytical chemistry and microbiology service lines.
- Becton, Dickinson and Company (BD): Major medical device and diagnostics company with microbiology and antimicrobial testing product lines (e.g., BD MAX, BD Phoenix). Serves many of the same pharma and clinical lab customers as Innovotech with broader scale and product portfolio.
- Intertek: Global TIC provider with pharmaceutical and medical device testing services including antimicrobial and biocompatibility testing. Comparable to Innovotech in serving medical device manufacturers with regulated testing workflows.
- Charles River Laboratories: Global CRO offering endotoxin, microbial detection, and antimicrobial/biological testing services to pharma and medical device manufacturers. Overlaps with Innovotech's GMP contract microbiology services but at much larger scale and broader scope.
- Eurofins Scientific: International testing laboratory group with extensive microbiology and antimicrobial testing capabilities for pharma, medical device, and consumer products. Competes with Innovotech's contract research and compendial microbiology services across multiple geographies.
Emerging players
- Accelerate Diagnostics: Specializes in rapid antimicrobial susceptibility testing and identification of pathogens, including biofilm-related infections. Comparable technology overlap with Innovotech's antimicrobial and biofilm susceptibility testing focus.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Innovotech social profiles
Digital presenceInnovotech compliance and trust
Trust signalCompliance3 records
Innovotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Innovotech leadership team
Management profileNumber of profiles
Profiles6 records
Innovotech subsidiaries and ownership
Company hierarchySubsidiaries1 record
Innovotech funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Innovotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Innovotech
What does Innovotech do?
Innovotech is a GMP- and ISO/IEC 17025-accredited contract research laboratory that provides antimicrobial and biofilm testing services to pharmaceutical, biotechnology, medical device, compounding pharmacy, and nutraceutical clients. The company also manufactures and sells its proprietary MBEC Assay® biofilm inoculator kits and InnovoSIL™ Silver antimicrobial product directly through its e-commerce storefront.
Is Innovotech a public or private company?
Innovotech is a public company. It is classified as public and is currently operating.
When was Innovotech founded?
Innovotech was founded in 2001. It employs 11 to 50 people.
Where is Innovotech based?
Innovotech is headquartered in Edmonton, Canada, in the North America region.
How does Innovotech make money?
Three revenue lines are on record. Contract Research Services are the primary driver. The others are MBEC Assay® Product Sales and innovoSIL™ Silver Product Sales.
Who are Innovotech's main competitors?
Direct peers on record are Nelson Laboratories, bioMérieux, Microbiologics and ATCC (American Type Culture Collection). Broad incumbents are SGS, Becton, Dickinson and Company (BD), Intertek, Charles River Laboratories and Eurofins Scientific. Accelerate Diagnostics is listed as an emerging player.
Does Innovotech have an API?
No public API is recorded for Innovotech.
What industry is Innovotech in?
Innovotech's product category is Contract Research & Antimicrobial Testing Services. Its primary akta.pro industry code is HLAGAEAF, Microbiology & Infectious Disease Testing (Trial Support). Its NAICS code is 541714 and its SIC code is 8731.